Skip to main content
NCBI home page
Biophysical Journal logoLink to Biophysical Journal
. 2001 Nov;81(5):2935–2945. doi: 10.1016/S0006-3495(01)75933-4

Role of native-state topology in the stabilization of intracellular antibodies.

G Settanni 1, A Cattaneo 1, A Maritan 1
PMCID: PMC1301757  PMID: 11606303

Abstract

The role played by the geometric position of each amino acid in the folding process of the immunoglobulin (Ig) variable domain is identified and measured through molecular dynamics simulations of models based on the topology of its native state. This measure allows identifying the parts of the protein that, for geometrical reasons, when mutated, would result in relevant protein stability changes. Simulations were performed without considering the covalent disulfide bond present in most of the Ig domains. The results are in good agreement with site-directed mutagenesis experiments on the folding of intracellular antibodies in which the disulfide bond does not form. We also found agreement with data on amino acid conservation in the Ig variable domain sequences. This indicates a new way for a rational approach to the design of intracellular antibodies more resistant to the suppression of the disulfide bond that occurs in the cytoplasm.

Full Text

The Full Text of this article is available as a PDF (463.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alm E., Baker D. Prediction of protein-folding mechanisms from free-energy landscapes derived from native structures. Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11305–11310. doi: 10.1073/pnas.96.20.11305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Banavar J. R., Maritan A. Computational approach to the protein-folding problem. Proteins. 2001 Mar 1;42(4):433–435. [PubMed] [Google Scholar]
  3. Biocca S., Neuberger M. S., Cattaneo A. Expression and targeting of intracellular antibodies in mammalian cells. EMBO J. 1990 Jan;9(1):101–108. doi: 10.1002/j.1460-2075.1990.tb08085.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Biocca S., Pierandrei-Amaldi P., Cattaneo A. Intracellular expression of anti-p21ras single chain Fv fragments inhibits meiotic maturation of xenopus oocytes. Biochem Biophys Res Commun. 1993 Dec 15;197(2):422–427. doi: 10.1006/bbrc.1993.2496. [DOI] [PubMed] [Google Scholar]
  5. Biocca S., Ruberti F., Tafani M., Pierandrei-Amaldi P., Cattaneo A. Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria. Biotechnology (N Y) 1995 Oct;13(10):1110–1115. doi: 10.1038/nbt1095-1110. [DOI] [PubMed] [Google Scholar]
  6. Bird R. E., Hardman K. D., Jacobson J. W., Johnson S., Kaufman B. M., Lee S. M., Lee T., Pope S. H., Riordan G. S., Whitlow M. Single-chain antigen-binding proteins. Science. 1988 Oct 21;242(4877):423–426. doi: 10.1126/science.3140379. [DOI] [PubMed] [Google Scholar]
  7. Cardinale A., Lener M., Messina S., Cattaneo A., Biocca S. The mode of action of Y13-259 scFv fragment intracellularly expressed in mammalian cells. FEBS Lett. 1998 Nov 20;439(3):197–202. doi: 10.1016/s0014-5793(98)01369-6. [DOI] [PubMed] [Google Scholar]
  8. Cattaneo A., Biocca S. The selection of intracellular antibodies. Trends Biotechnol. 1999 Mar;17(3):115–121. doi: 10.1016/s0167-7799(98)01268-2. [DOI] [PubMed] [Google Scholar]
  9. Cecconi F., Micheletti C., Carloni P., Maritan A. Molecular dynamics studies on HIV-1 protease drug resistance and folding pathways. Proteins. 2001 Jun 1;43(4):365–372. [PubMed] [Google Scholar]
  10. Chiti F., Taddei N., White P. M., Bucciantini M., Magherini F., Stefani M., Dobson C. M. Mutational analysis of acylphosphatase suggests the importance of topology and contact order in protein folding. Nat Struct Biol. 1999 Nov;6(11):1005–1009. doi: 10.1038/14890. [DOI] [PubMed] [Google Scholar]
  11. Clementi C., Nymeyer H., Onuchic J. N. Topological and energetic factors: what determines the structural details of the transition state ensemble and "en-route" intermediates for protein folding? An investigation for small globular proteins. J Mol Biol. 2000 May 19;298(5):937–953. doi: 10.1006/jmbi.2000.3693. [DOI] [PubMed] [Google Scholar]
  12. Duan L., Zhang H., Oakes J. W., Bagasra O., Pomerantz R. J. Molecular and virological effects of intracellular anti-Rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strains. Hum Gene Ther. 1994 Nov;5(11):1315–1324. doi: 10.1089/hum.1994.5.11-1315. [DOI] [PubMed] [Google Scholar]
  13. Ferrenberg AM, Swendsen RH. Optimized Monte Carlo data analysis. Phys Rev Lett. 1989 Sep 18;63(12):1195–1198. doi: 10.1103/PhysRevLett.63.1195. [DOI] [PubMed] [Google Scholar]
  14. Freire E., Murphy K. P., Sanchez-Ruiz J. M., Galisteo M. L., Privalov P. L. The molecular basis of cooperativity in protein folding. Thermodynamic dissection of interdomain interactions in phosphoglycerate kinase. Biochemistry. 1992 Jan 14;31(1):250–256. doi: 10.1021/bi00116a034. [DOI] [PubMed] [Google Scholar]
  15. Frisch C., Kolmar H., Fritz H. J. A soluble immunoglobulin variable domain without a disulfide bridge: construction, accumulation in the cytoplasm of E. coli, purification and physicochemical characterization. Biol Chem Hoppe Seyler. 1994 May;375(5):353–356. [PubMed] [Google Scholar]
  16. Galzitskaya O. V., Finkelstein A. V. A theoretical search for folding/unfolding nuclei in three-dimensional protein structures. Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11299–11304. doi: 10.1073/pnas.96.20.11299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gargano N., Cattaneo A. Inhibition of murine leukaemia virus retrotranscription by the intracellular expression of a phage-derived anti-reverse transcriptase antibody fragment. J Gen Virol. 1997 Oct;78(Pt 10):2591–2599. doi: 10.1099/0022-1317-78-10-2591. [DOI] [PubMed] [Google Scholar]
  18. Gilbert H. F. Molecular and cellular aspects of thiol-disulfide exchange. Adv Enzymol Relat Areas Mol Biol. 1990;63:69–172. doi: 10.1002/9780470123096.ch2. [DOI] [PubMed] [Google Scholar]
  19. Go N. Theoretical studies of protein folding. Annu Rev Biophys Bioeng. 1983;12:183–210. doi: 10.1146/annurev.bb.12.060183.001151. [DOI] [PubMed] [Google Scholar]
  20. Goto Y., Hamaguchi K. The role of the intrachain disulfide bond in the conformation and stability of the constant fragment of the immunoglobulin light chain. J Biochem. 1979 Nov;86(5):1433–1441. doi: 10.1093/oxfordjournals.jbchem.a132661. [DOI] [PubMed] [Google Scholar]
  21. Gunasekaran K., Eyles S. J., Hagler A. T., Gierasch L. M. Keeping it in the family: folding studies of related proteins. Curr Opin Struct Biol. 2001 Feb;11(1):83–93. doi: 10.1016/s0959-440x(00)00173-1. [DOI] [PubMed] [Google Scholar]
  22. Huston J. S., Levinson D., Mudgett-Hunter M., Tai M. S., Novotný J., Margolies M. N., Ridge R. J., Bruccoleri R. E., Haber E., Crea R. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci U S A. 1988 Aug;85(16):5879–5883. doi: 10.1073/pnas.85.16.5879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hwang C., Sinskey A. J., Lodish H. F. Oxidized redox state of glutathione in the endoplasmic reticulum. Science. 1992 Sep 11;257(5076):1496–1502. doi: 10.1126/science.1523409. [DOI] [PubMed] [Google Scholar]
  24. Improta S., Politou A. S., Pastore A. Immunoglobulin-like modules from titin I-band: extensible components of muscle elasticity. Structure. 1996 Mar 15;4(3):323–337. doi: 10.1016/s0969-2126(96)00036-6. [DOI] [PubMed] [Google Scholar]
  25. Johnson G., Wu T. T. Kabat database and its applications: 30 years after the first variability plot. Nucleic Acids Res. 2000 Jan 1;28(1):214–218. doi: 10.1093/nar/28.1.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Jung S., Plückthun A. Improving in vivo folding and stability of a single-chain Fv antibody fragment by loop grafting. Protein Eng. 1997 Aug;10(8):959–966. doi: 10.1093/protein/10.8.959. [DOI] [PubMed] [Google Scholar]
  27. Kolmar H., Frisch C., Götze K., Fritz H. J. Immunoglobulin mutant library genetically screened for folding stability exploiting bacterial signal transduction. J Mol Biol. 1995 Aug 25;251(4):471–476. doi: 10.1006/jmbi.1995.0448. [DOI] [PubMed] [Google Scholar]
  28. Langedijk A. C., Honegger A., Maat J., Planta R. J., van Schaik R. C., Plückthun A. The nature of antibody heavy chain residue H6 strongly influences the stability of a VH domain lacking the disulfide bridge. J Mol Biol. 1998;283(1):95–110. doi: 10.1006/jmbi.1998.2064. [DOI] [PubMed] [Google Scholar]
  29. Marasco W. A. Intracellular antibodies (intrabodies) as research reagents and therapeutic molecules for gene therapy. Immunotechnology. 1995 May;1(1):1–19. doi: 10.1016/1380-2933(95)00001-1. [DOI] [PubMed] [Google Scholar]
  30. Maritan A., Micheletti C., Banavar J. R. Role of secondary motifs in fast folding polymers: a dynamical variational principle. Phys Rev Lett. 2000 Mar 27;84(13):3009–3012. doi: 10.1103/PhysRevLett.84.3009. [DOI] [PubMed] [Google Scholar]
  31. Maritan A., Micheletti C., Trovato A., Banavar J. R. Optimal shapes of compact strings. Nature. 2000 Jul 20;406(6793):287–290. doi: 10.1038/35018538. [DOI] [PubMed] [Google Scholar]
  32. Martineau P., Jones P., Winter G. Expression of an antibody fragment at high levels in the bacterial cytoplasm. J Mol Biol. 1998 Jul 3;280(1):117–127. doi: 10.1006/jmbi.1998.1840. [DOI] [PubMed] [Google Scholar]
  33. Martinez J. C., Pisabarro M. T., Serrano L. Obligatory steps in protein folding and the conformational diversity of the transition state. Nat Struct Biol. 1998 Aug;5(8):721–729. doi: 10.1038/1418. [DOI] [PubMed] [Google Scholar]
  34. Mhashilkar A. M., Bagley J., Chen S. Y., Szilvay A. M., Helland D. G., Marasco W. A. Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies. EMBO J. 1995 Apr 3;14(7):1542–1551. doi: 10.1002/j.1460-2075.1995.tb07140.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Muñoz V., Henry E. R., Hofrichter J., Eaton W. A. A statistical mechanical model for beta-hairpin kinetics. Proc Natl Acad Sci U S A. 1998 May 26;95(11):5872–5879. doi: 10.1073/pnas.95.11.5872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Nieba L., Honegger A., Krebber C., Plückthun A. Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment. Protein Eng. 1997 Apr;10(4):435–444. doi: 10.1093/protein/10.4.435. [DOI] [PubMed] [Google Scholar]
  37. Niggemann M., Steipe B. Exploring local and non-local interactions for protein stability by structural motif engineering. J Mol Biol. 2000 Feb 11;296(1):181–195. doi: 10.1006/jmbi.1999.3385. [DOI] [PubMed] [Google Scholar]
  38. Proba K., Honegger A., Plückthun A. A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding. J Mol Biol. 1997 Jan 17;265(2):161–172. doi: 10.1006/jmbi.1996.0726. [DOI] [PubMed] [Google Scholar]
  39. Proba K., Wörn A., Honegger A., Plückthun A. Antibody scFv fragments without disulfide bonds made by molecular evolution. J Mol Biol. 1998 Jan 16;275(2):245–253. doi: 10.1006/jmbi.1997.1457. [DOI] [PubMed] [Google Scholar]
  40. Richardson J. H., Marasco W. A. Intracellular antibodies: development and therapeutic potential. Trends Biotechnol. 1995 Aug;13(8):306–310. doi: 10.1016/S0167-7799(00)88970-2. [DOI] [PubMed] [Google Scholar]
  41. Rudikoff S., Pumphrey J. G. Functional antibody lacking a variable-region disulfide bridge. Proc Natl Acad Sci U S A. 1986 Oct;83(20):7875–7878. doi: 10.1073/pnas.83.20.7875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Tavladoraki P., Benvenuto E., Trinca S., De Martinis D., Cattaneo A., Galeffi P. Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack. Nature. 1993 Dec 2;366(6454):469–472. doi: 10.1038/366469a0. [DOI] [PubMed] [Google Scholar]
  43. Vendruscolo M., Najmanovich R., Domany E. Can a pairwise contact potential stabilize native protein folds against decoys obtained by threading? Proteins. 2000 Feb 1;38(2):134–148. doi: 10.1002/(sici)1097-0134(20000201)38:2<134::aid-prot3>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  44. Visintin M., Tse E., Axelson H., Rabbitts T. H., Cattaneo A. Selection of antibodies for intracellular function using a two-hybrid in vivo system. Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):11723–11728. doi: 10.1073/pnas.96.21.11723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Williams A. F., Barclay A. N. The immunoglobulin superfamily--domains for cell surface recognition. Annu Rev Immunol. 1988;6:381–405. doi: 10.1146/annurev.iy.06.040188.002121. [DOI] [PubMed] [Google Scholar]
  46. Wolynes P. G., Onuchic J. N., Thirumalai D. Navigating the folding routes. Science. 1995 Mar 17;267(5204):1619–1620. doi: 10.1126/science.7886447. [DOI] [PubMed] [Google Scholar]
  47. Wörn A., Plückthun A. Different equilibrium stability behavior of ScFv fragments: identification, classification, and improvement by protein engineering. Biochemistry. 1999 Jul 6;38(27):8739–8750. doi: 10.1021/bi9902079. [DOI] [PubMed] [Google Scholar]
  48. Wörn A., Plückthun A. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability. Biochemistry. 1998 Sep 22;37(38):13120–13127. doi: 10.1021/bi980712q. [DOI] [PubMed] [Google Scholar]

Articles from Biophysical Journal are provided here courtesy of The Biophysical Society

RESOURCES